L-Glutathione

Batch #513219Batch # 513219
Report #53447Report # 53447
Tested at99.8% purityTested at 99.8% purity
Size: 200mg
Money Back Guarantee Money Back Guarantee
Satisfaction Guarantee Satisfaction Guarantee
Easy Returns Easy Returns
Secure Ordering Secure Ordering
2-Day Shipping 2-Day Shipping
Third Party Tested Third Party Tested
Batch & Lot Tracking Batch & Lot Tracking

RESEARCH USE ONLY
These compounds are NOT intended for human consumption, clinical use, or veterinary applications. We are not affiliated with any pharmaceutical companies or their commercial medications. By placing an order, you certify these materials will be used exclusively for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

About L-Glutathione

L-glutathione is a naturally occurring tripeptide composed of glutamine cysteine and glycine. It has been studied for its role in cellular processes such as antioxidant activity detoxification and maintaining cellular health. Research has focused on its potential involvement in supporting redox balance protecting cells from oxidative stress and participating in various metabolic pathways.

Product Specifications

L-Glutathione in 10ml vial.

Application

An antioxidant used in various research studies including cellular protection and detoxification research.

Solubility

Soluble in water

Chemical Formula

C10H17N3O6S

PubChem CID

124886

Organoleptic Profile

Clear, colorless liquid

L-Glutathione CAS Number

70-18-8

Molecular Weight

307.32 g/mol

Synonyms

GSH

Storage

Store at room temperature

1. Clinical Overview

L-glutathione (GSH) is a tripeptide (glutamate-cysteine-glycine) and the body’s most abundant intracellular antioxidant. It maintains cellular redox balance, supports phase II detoxification, and modulates immune function. In skin biology, GSH can inhibit tyrosinase and shift melanogenesis toward lighter pheomelanin, mechanisms that help explain its appearance in hyperpigmentation research. 

Beyond dermatology, oral GSH has been shown to raise systemic GSH stores and favorably influence oxidative-stress and some metabolic markers in human studies. 

2. Human Clinical Findings

Skin pigmentation

• Randomized, double-blind, placebo-controlled trial (n=60, 4 weeks) in healthy adults: oral GSH 500 mg/day (250 mg BID) reduced melanin index at several body sites vs placebo; treatment was well tolerated. 

Body GSH stores & immune markers

• RCT (n=54, 6 months): oral GSH 250 or 1000 mg/day increased GSH 30–35% in erythrocytes/plasma/lymphocytes (up to 260% in buccal cells with 1000 mg), lowered oxidized:reduced GSH ratio, and more than doubled NK-cell cytotoxicity at 3 months; values returned to baseline after washout. 

• Pilot (n=12, 4 weeks): liposomal GSH 500 or 1000 mg/day raised whole-blood GSH (max ~40%), reduced plasma 8-isoprostane (~35%), and increased NK-cell activity (up to 400%). 

Glucose metabolism

• Randomized, double-blind, placebo-controlled trial (n=20, 3 weeks) in obese men with/without type 2 diabetes: oral GSH 1000 mg/day significantly improved whole-body insulin sensitivity by hyperinsulinemic-euglycemic clamp. 

• Pragmatic randomized clinical trial in type 2 diabetes (n=250; 6 months): oral GSH 500 mg/day increased blood GSH, reduced 8-OHdG, and in participants ≥55 years lowered HbA1c and increased fasting insulin vs standard care. 

3. Mechanism & Effects

GSH directly and indirectly inhibits tyrosinase (e.g., copper chelation at the active site) and can steer melanogenesis toward pheomelanin via thiol-DOPA conjugation, collectively reducing eumelanin production. Its antioxidant action also suppresses ROS-driven melanogenic signaling. Systemically, higher intracellular GSH supports immune cell function and redox homeostasis; oral (including liposomal) forms have demonstrated increases in circulating and cellular GSH in humans. 

4. Safety & Considerations

Across short- to mid-term human trials, oral L-glutathione was generally well tolerated, with no serious adverse events reported in healthy adults or in the diabetes studies noted above. Dermatology reviews likewise judge oral/topical use as having a favorable short-term safety profile, though larger, longer trials are still needed. 

By contrast, intravenous glutathione for cosmetic skin lightening has limited efficacy data and has drawn safety warnings from regulators and dermatology authors. In 2019, the U.S. FDA highlighted adverse events from compounded injectable glutathione linked to excessive endotoxin contamination and emphasized that dietary-grade glutathione should not be used to compound sterile injectables. Reviews also caution about adverse effects reported with cosmetic IV use and a lack of robust evidence for skin-lightening indications. 

References

  1. Arjinpathana N, Asawanonda P. J Dermatolog Treat. 2012. Oral glutathione as a skin-lightening agent (double-blind RCT). 
  2. Richie JP Jr, et al. Eur J Nutr. 2015. Randomized controlled trial of oral glutathione on body stores and immune markers. 
  3. Sinha R, et al. Eur J Clin Nutr. 2018. Liposomal oral glutathione elevates body stores and immune markers (pilot). 
  4. Søndergård SD, et al. Appl Physiol Nutr Metab. 2021. Oral glutathione improves insulin sensitivity in obese men (RCT). 
  5. Kalamkar S, et al. Antioxidants (Basel). 2022. Long-term oral glutathione in elderly type 2 diabetics (randomized pragmatic trial). 
  6. Sonthalia S, et al. Pigment Int. 2017. Update on glutathione for skin lightening—mechanisms, evidence, and concerns with IV use. 
  7. Lu Y, et al. Biosci Rep. 2021. Review: thioredoxin and glutathione systems in melanogenesis (mechanistic overview). 
  8. U.S. FDA. 2019. Compounding alert: concerns using dietary-ingredient glutathione to compound sterile injectables (endotoxin-related AEs). 

 

You ask,
we answer.